Delfi Diagnostics is a biotechnology company with a mission to use its technology for early cancer detection. By developing AI and ML algorithms, Delfi Diagnostics offers predictive testing processes with the goal of maximizing patient survival rates. The company specializes in the detection of breast cancer and aims to help healthcare organizations minimize treatment toxicity with less-invasive treatments. Delfi Diagnostics was founded by Alessandro Leal and Victor Velculescu in 2019 and is headquartered in Baltimore, MD.

Register for Details

For more details on financing and valuation for Delfi Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Delfi Diagnostics

Forge green plus iconForge green minus icon

Is Delfi Diagnostics a publicly traded company?

Delfi Diagnostics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Delfi Diagnostics go IPO?

Delfi Diagnostics has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Delfi Diagnostics's IPO price?

The IPO price for Delfi Diagnostics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Delfi Diagnostics pre-IPO?

Delfi Diagnostics is privately held company and is not publicly traded, therefor investing in Delfi Diagnostics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Delfi Diagnostics shares?

To determine the value of your Delfi Diagnostics shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Delfi Diagnostics shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Delfi Diagnostics before it goes public?

Yes, you can seek to sell shares in Delfi Diagnostics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Delfi Diagnostics's funding to date?

Delfi Diagnostics has raised $326.47MM to date.
Forge green plus iconForge green minus icon

When was Delfi Diagnostics founded?

Delfi Diagnostics was founded in 2019.

Who are Delfi Diagnostics's major investors?

Menlo Ventures
DFJ Growth
Point72 Ventures
Foresite Capital
Rock Springs Capital
T. Rowe price
Samsara Biocapital
Windham Venture Partners
Osage University Partners
OrbiMed
Point Field Partners
Open Field Capital
Johns Hopkins Technology Ventures
PTX Capital
Illumina Ventures
Cowen Healthcare Investments
Northpond Ventures

Delfi Diagnostics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
7/18/2022

Series B

$225MM raised $XXX.XX $XXX.XX
1/12/2021

Series A

$95.97MM raised $XXX.XX $XXX.XX
8/12/2019

Series Seed

$5.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 24, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.